Genes, chromosomes & cancer

publication venue for

FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor. 2022
Low-grade endometrial stromal sarcoma-like tumors in male with JAZF1 gene fusions. 2021
BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall. 2017
EWSR1-PBX3: a novel gene fusion in myoepithelial tumors. 2014
A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis. 2000
Leukemic differentiation of a mediastinal germ cell tumor. 1989
Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.. 60. 2021
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.. 59. 2019
Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics.. 57. 2018
Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia.. 56. 2016
Identification of DNA double strand breaks at chromosome boundaries along the track of particle irradiation.. 55. 2016
Genomic aberrations frequently alter chromatin regulatory genes in chordoma.. 55. 2016
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancer.. 55. 2016
Detection and screening of chromosomal rearrangements in uterine leiomyomas by long-distance inverse PCR.. 55. 2015
Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.. 55. 2015
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.. 54. 2015
Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysis.. 54. 2015
Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing.. 54. 2014
Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.. 53. 2014
Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.. 53. 2014
Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study.. 53. 2014
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.. 53. 2014
Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.. 53. 2013
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line.. 53. 2013
Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases.. 52. 2013
Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.. 52. 2013
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.. 52. 2013
Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.. 52. 2013
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.. 52. 2013
Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.. 51. 2012
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.. 51. 2012
Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.. 51. 2011
CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.. 51. 2011
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.. 51. 2011
Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.. 51. 2011
Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.. 50. 2011
A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.. 50. 2011
Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.. 50. 2011
mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.. 50. 2011
Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.. 50. 2011
Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.. 50. 2011
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.. 49. 2010
WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?. 48. 2009
Distinct genomic aberrations associated with ERG rearranged prostate cancer.. 48. 2009
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.. 47. 2008
In vivo differentiation and genomic evolution in adult male germ cell tumors.. 47. 2008
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.. 46. 2007
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.. 45. 2006
Amplification and overexpression of prosaposin in prostate cancer.. 44. 2005
Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.. 41. 2004
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.. 41. 2004
Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.. 40. 2004
Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.. 39. 2004
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.. 39. 2004
Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.. 36. 2003
Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma.. 35. 2002
Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.. 35. 2002
Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.. 33. 2002
Defining a common region of deletion at 13q21 in human cancers.. 31. 2001
MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.. 28. 2000
Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.. 27. 2000
Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.. 23. 1998
Comparative genomic hybridization for genetic analysis of renal oncocytomas.. 17. 1996
Translocation t(8;13)(p11;q11-12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages.. 12. 1995
Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma.. 11. 1994
Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas.. 10. 1994
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors.. 8. 1993
Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.. 7. 1993
A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma.. 6. 1993
Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization.. 5. 1992
Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer.. 3. 1991
Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridization.. 3. 1991
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.. 3. 1991
Abnormalities of 2q: a common genetic link between rhabdomyosarcoma and hepatoblastoma?. 3. 1991
Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.. 2. 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.. 1. 1990
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction.. 1. 1990
Reply to Cristóbal and Co-authors' comment, deregulation of miR-92a in locally advanced rectal cancer. 2016
Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas. 2007
Clonal cytogenetic abnormalities in Hodgkin's disease. 1991

VIVO Weill Cornell Medical College

Genes, chromosomes & cancer Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)